Progress Reports in the Battle against Acquired Immune Deficiency Syndrome

FDA Consumer, October 1989 | Go to article overview

Progress Reports in the Battle against Acquired Immune Deficiency Syndrome


Progress Reports in the Battle Against Acquired Immune Deficiency Syndrome

Toll-Free AIDS Information

Information on privately funded clinical trials of drugs and biologies used to treat AIDS and AIDS-related illnesses is now available through a toll-free telephone service.

Since July, FDA has been providing information on privately funded trials to a special AIDS telephone line, the Public Health Service's AIDS Information Service. Information on NIH-sponsored AIDS and AIDS-related clinical trials has been available through the telephone line since May.

The toll-free telephone service is staffed by specially trained health information specialists, including some who speak Spanish. Service for the hearing impaired is also available. Information from the phone service is also accessible through DIRLINE, the National Library of Medicine's online computer data base. All inquiries are kept confidential.

By dialing 1-800-TRIALS-A, callers can find out: * where studies are located, and the eligibility criteria for participants, * the name of the product being studied and the purpose of the study, and * a contact and phone number for the company that is sponsoring the clinical trials.

FDA's participation in this telephone service is a response to a new law, the Omnibus Health Programs Extension Act of 1988, which requires that the Secretary of Health and Human Services establish a data base on AIDS-related clinical trials for public use. Before, such information was considered confidential and could not be publicly disclosed.

The new law requires sponsors to release information only about product effectiveness trials. However, FDA is encouraging them to list all trials involving AIDS or AIDS-related products, such as safety trials, and to release more information than is strictly required by the new law. For example, a company could provide the name, address, and telephone number of investigators conducting a particular study and more information about the trial, such as duration and need for hospitalization.

Zidovudine for Pregnant Women

FDA recently sanctioned the first trials of the AIDS drug zidovudine (also called AZT) in pregnant women infected with the AIDS virus, to see if it can protect newborns from the disease.

As part of the study, zidovudine, the only approved antiviral AIDS drug, will be given in the third trimester of pregnancy to 10 women who are infected with the human immunodeficiency virus (HIV), but who have no disease symptoms. Though not a cure for AIDS, zidovudine can prolong survival and improve the quality of life for those stricken.

Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, the sponsor of the tests, said the experiment is an effort to find a way of treating one of the fastest-growing categories of AIDS patients, newborn babies. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Progress Reports in the Battle against Acquired Immune Deficiency Syndrome
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.